Company Filing History:
4 out of 444 
4 out of 5,450 
Years Active: 2010-2015
Title: Young-Ah Moon: Innovator in RNAi Modulation
Introduction
Young-Ah Moon is a prominent inventor based in Irving, Texas, known for his significant contributions to the field of molecular biology. He holds four patents, showcasing his innovative approach to scientific challenges. His work primarily focuses on the modulation of gene expression, particularly through RNA interference (RNAi).
Latest Patents
One of Young-Ah Moon's latest patents is titled "RNAi modulation of SCAP and therapeutic uses thereof." This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the SCAP gene, which is crucial in various biological processes. The dsRNA comprises an antisense strand with a nucleotide sequence typically ranging from 19 to 25 nucleotides in length, which is substantially complementary to a portion of the SCAP gene. The patent also details a pharmaceutical composition that includes the dsRNA along with a pharmaceutically acceptable carrier. Furthermore, it outlines methods for treating diseases associated with Human SCAP expression and techniques for inhibiting SCAP gene expression in cells.
Career Highlights
Throughout his career, Young-Ah Moon has worked with notable organizations, including Alnylam Pharmaceuticals, Inc. and the University of Texas System. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Young-Ah Moon has collaborated with esteemed colleagues such as Juergen Soutschek and Pamela Tan. These partnerships have played a vital role in enhancing his research and expanding the impact of his inventions.
Conclusion
Young-Ah Moon's work in RNAi modulation represents a significant advancement in the field of gene therapy. His innovative patents and collaborations highlight his commitment to addressing complex biological challenges. His contributions continue to pave the way for future developments in therapeutic applications.